CanaQuest Medical Corp. Stock Analysis CANQF

CanaQuest Medical Corp. is a pharmaceutical company, which is focused on the medical cannabis products, utilizing cannabinoid molecules, and other botanical compounds. The company is headquartered in Mississauga, Ontario. The company went IPO on 2014-10-27. The firm is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post-Traumatic Stress Disorder (PTSD). The company has created a natural formulation derived from cannabidiol + proprietary API composition. The firm is focused on CQ-001, its proprietary drug candidate that combines cannabidiol (CBD) with essential fatty acids (Omega-3s). CQ-001 is positioned for clinical trials targeting epilepsy. The firm is also developing a nutraceutical version of this formulation, called Mentanine, which is scheduled for clinical studies to explore its potential use for various conditions. The firm has a wholly owned subsidiary, ADC BioMedical Corp.